Skip to content
The Policy VaultThe Policy Vault

Lyrica (pregabalin immediate-release)CareFirst (Caremark)

Cancer-related neuropathic pain

Preferred products

  • gabapentin immediate-release

Initial criteria

  • The request is for Lyrica (pregabalin immediate-release).
  • The requested drug is being prescribed for ONE of the listed indications.
  • If the request is for Lyrica oral solution, the patient has difficulty swallowing oral solid dosage forms OR requires a dose that cannot be obtained using the commercially available capsules.

Reauthorization criteria

  • The request is for Lyrica (pregabalin immediate-release).
  • The requested drug is being prescribed for ONE of the same listed indications.
  • If the request is for Lyrica oral solution, the patient has difficulty swallowing oral solid dosage forms OR requires a dose that cannot be obtained using the commercially available capsules.
  • The patient has achieved or maintained a positive clinical response to the requested drug.

Approval duration

12 months